ReviewDrugs in R&D2019
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later.
Pawel Robak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
78 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewDrugs in R&D2019
Pawel Robak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.